BP’s Allergan plc AGN Stock Holding History

BP’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-34,000	Closed	-$6.01M	–	554
2020 Q1	$6.01M	Hold	34,000	–	–	0.26%	89
2019 Q4	$6.49M	Hold	34,000	–	–	0.22%	108
2019 Q3	$5.72M	Hold	34,000	–	–	0.21%	113
2019 Q2	$5.7M	Sell	34,000 -2,000	-6%	-$277K	0.21%	117
2019 Q1	$5.27M	Hold	36,000	–	–	0.2%	126
2018 Q4	$4.81M	Sell	36,000 -50,000	-58%	-$8.2M	0.2%	127
2018 Q3	$16.4M	Buy	86,000 +43,400	+102%	+$7.97M	0.5%	48
2018 Q2	$7.11M	Buy	42,600 +5,200	+14%	+$835K	0.23%	107
2018 Q1	$6.29M	Buy	37,400 +13,400	+56%	+$2.25M	0.23%	120
2017 Q4	$3.93M	Sell	24,000 -15,000	-38%	-$2.69M	0.14%	189
2017 Q3	$7.99M	Hold	39,000	–	–	0.28%	95
2017 Q2	$9.48M	Sell	39,000 -15,500	-28%	-$3.64M	0.35%	85
2017 Q1	$13M	Buy	54,500 +17,000	+45%	+$3.96M	0.49%	52
2016 Q4	$7.88M	Sell	37,500 -6,500	-15%	-$1.35M	0.3%	91
2016 Q3	$10.1M	Hold	44,000	–	–	0.39%	73
2016 Q2	$10.2M	Sell	44,000 -6,000	-12%	-$1.38M	0.4%	75
2016 Q1	$13.4M	Sell	50,000 -20,000	-29%	-$5.73M	0.54%	54
2015 Q4	$21.9M	Sell	70,000 -22,000	-24%	-$6.55M	0.9%	25
2015 Q3	$25M	Sell	92,000 -8,000	-8%	-$2.46M	1.12%	15
2015 Q2	$30.4M	Buy	100,000 +7,164	+8%	+$2.14M	1.14%	14
2015 Q1	$27.6M	Buy	92,836 +33,836	+57%	+$9.65M	0.88%	18
2014 Q4	$15.2M	Buy	59,000 +26,000	+79%	+$6.5M	0.39%	66
2014 Q3	$7.96M	Sell	33,000 -15,000	-31%	-$3.36M	0.23%	114
2014 Q2	$10.7M	Hold	48,000	–	–	0.34%	67
2014 Q1	$9.89M	Sell	48,000 -24,000	-33%	-$4.75M	0.33%	72
2013 Q4	$12.1M	Buy	+72,000	New	+$11.3M	0.44%	54

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

BP's AGN Position: Q2 2020 in Review

BP sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 34,000 shares — an estimated $6.01M sold.

BP first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $30.4M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

BP reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
BP sold 34,000 Allergan plc shares in Q2 2020, an estimated $6.01M.
BP first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
BP's Allergan plc position peaked at $30.4M in Q2 2015.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on BP's 13F filing for Q2 2020, filed 5 Aug 2020.